Sp1290
EVIDENCE BEYOND CLINICAL TRIALS: STELARA® REAL-WORLD EVIDENCE IN BIO-NAÏVE ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (CD) OR ULCERATIVE COLITIS (UC)
Date
May 19, 2024
Presenters
Tracks
Related Products
RNA SEQUENCING FROM BIOPSIES PERFORMED DURING FOOD ELIMINATION AND REINTRODUCTION IDENTIFIES SIGNATURES INVOLVED IN EARLY RECURRENCE OF EOE
RATIONALE: RNA sequencing studies have previously identified impaired barrier function and the subsequent proinflammatory response as critical to the pathogenies of EoE. However, the investigation into disease initiation is often limited by the inability to capture the disease early…
COMPARATIVE ANALYSIS OF GENE EXPRESSION PROFILES OF ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS BASED ON ANATOMICAL CLASSIFICATION
BACKGROUND: Siewert's topographic classification (SW) has been used for treatment plan of esophagogastric junction adenocarcinomas (EGJA). But recently, molecular classifications categorized EGJA with similar characteristics and prognosis…
THE IMPORTANCE OF LONG-TERM CLINICAL OUTCOMES IN BIO-NAIVE PATIENTS
This case based presentation will highlight the importance of long-term clinical outcomes in bio-naive patients across both Crohn's disease and ulcerative colitis. Sponsored by Janssen Biotech, Inc…